Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Lomb Ord Shs BLCO


Primary Symbol: T.BLCO

Healthcare Medical Devices
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative... see more

Recent & Breaking News (TSX:BLCO)

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Business Wire 21 hours ago

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Business Wire November 14, 2024

Bausch + Lomb Announces Third-Quarter 2024 Results

Business Wire October 30, 2024

Bausch + Lomb Receives FDA Approval for enVista® Envy(TM) Full Range of Vision Intraocular Lens

Business Wire October 14, 2024

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

Business Wire October 9, 2024

Bausch + Lomb Launches Opal(TM) Digital Marketplace in the United States

Business Wire October 1, 2024

Bausch + Lomb Announces Second-Quarter 2024 Results

Business Wire July 31, 2024

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

Business Wire July 11, 2024

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

Business Wire July 8, 2024

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

Business Wire June 17, 2024

Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

Business Wire June 10, 2024

Bausch + Lomb Launches Blink(TM) NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States

Business Wire June 3, 2024

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

Business Wire May 29, 2024

Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting®

Business Wire May 28, 2024

Bausch + Lomb Receives Health Canada Approval for enVista® Envy(TM)* Full Visual Range Intraocular Lens

Business Wire May 28, 2024

Bausch + Lomb Announces First-Quarter 2024 Results

Business Wire May 1, 2024

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

Business Wire April 29, 2024

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

Business Wire April 25, 2024

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

Business Wire April 18, 2024

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

Business Wire April 15, 2024